title: Two critical periods of protein and glycoprotein synthesis in memory consolidation for visual categorization learning in chicks.
abstract: A protein synthesis inhibitor, anisomycin (ANI), and an inhibitor of glycoprotein synthesis, 2-deoxygalactose (2-D-gal), were used to investigate memory consolidation following visual categorization training in 2-day-old chicks. ANI (0.6 micromole/chick) and 2-D-gal (40 micromoles/chick) were injected intracerebrally at different time intervals from 1 hr before to 23 hr after the training. Retention was tested 24 hr post-training. Both ANI and 2-D-gal injections revealed two periods of memory sensitivity to pharmacological intervention. ANI impaired retention when injected from 5 min before to 30 min after the training or from 4 hr to 5 hr post-training, thus demonstrating that consolidation of long-term memory in this task requires two periods of protein synthesis. 2-D-Gal first produced an amnesia when it was injected in the interval from 5 min before to 5 min after the training. Injections made between 5 min and 5 hr post-training were without effect on the retention. The second period of memory impairment by 2-D-gal started at 5 hr post-training and lasted until 21 hr after the training. Administration of 2-D-gal made 23 hr after the training did not influence retention in the test at either 24 hr or 26 hr. These results are consistent with the hypothesis that two waves of protein and glycoprotein synthesis are necessary for the formation of long-term memory. The prolonged duration of performance impairment by 2-D-gal in the present task might reflect an extended memory consolidation period for a categorization form of learning.
authors.affiliation: P.K. Anokhin Institute of Normal Physiology, Moscow, Russia.
authors.forename: A A
authors.initials: AA
authors.lastname: Tiunova
authors.forename: K V
authors.initials: KV
authors.lastname: Anokhin
authors.forename: S P
authors.initials: SP
authors.lastname: Rose
mesh_terms: D000818:Animals; D000841:Anisomycin / Q000494:pharmacology; D001921:Brain; D003423:Critical Period, Psychological; D005260:Female; D005643:Fucose / Q000494:pharmacology; D005690:Galactose / Q000494:pharmacology; D006023:Glycoproteins / Q000096:biosynthesis*; D007267:Injections; D007858:Learning / Q000502:physiology*; D008297:Male; D008568:Memory / Q000502:physiology*; D009419:Nerve Tissue Proteins / Q000096:biosynthesis*; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D012153:Retention, Psychology / Q000187:drug effects; D013997:Time Factors; D014795:Visual Pathways / Q000502:physiology*
chemical_list: D006023:Glycoproteins; D009419:Nerve Tissue Proteins; D011500:Protein Synthesis Inhibitors; D005643:Fucose; D000841:Anisomycin; D005690:Galactose